Srividhya Venkatesan

Author

Yale University

Also Known As

S Venkatesan, S. Venkatesan, Srividhya Venkatesan

Publications

481

Citations

H-Index

Concepts

All Affiliations

Yale University Yale Cancer Center University of Pittsburgh

About

Srividhya Venkatesan is an author at Yale University specializing in immunology, autoimmunity, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	209
2	Immunology	4	4	209
3	Cell Biology	3	3	140
4	Cellular Physiology	1	1	47
5	Cellular Therapies	1	1	29

Srividhya Venkatesan

Publications

376

Citations

H-Index

Page 1

	Year	Citations
Histones to the cytosol: exportin 7 is essential for normal terminal erythroid nuclear maturation Shilpa M. Hattangadi, Sandra Martínez-Morilla, Heide Christine Patterson, Blood	2014	75
PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens Martina Damo, Noah I. Hornick, Aarthi Venkat, Nature ImmunologyAutoimmunityDermatologyCellular Immune ResponseImmunotherapy	2023	69
Graft-versus-Host Disease Is Independent of Innate Signaling Pathways Triggered by Pathogens in Host Hematopoietic Cells Hongmei Li‐Byarlay, Catherine Matte-Martone, Hung Sheng Tan, The Journal of Immunology Adaptive Immune SystemInnate Immune SystemImmunologyImmune RegulationPathology	2010	64
Memory T cells from minor histocompatibility antigen–vaccinated and virus-immune donors improve GVL and immune reconstitution Ning Li, Catherine Matte-Martone, Hong Zheng, Blood	2011	50
Phosphorylation of the Linker for Activation of T-Cells by Itk Promotes Recruitment of Vav Juan J. Pérez‐Villar, Gena S. Whitney, Mitchell Sitnick, Biochemistry Adaptive Immune SystemT-regulatory CellImmunologyImmunologic MechanismImmunotherapy	2002	47
Langerhans cells are not required for graft-versus-host disease Hongmei Li, Daniel H. Kaplan, Catherine Matte-Martone, Blood	2010	42
Graft-versus-Leukemia (GVL) against Mouse Blast-Crisis Chronic Myelogenous Leukemia (BC-CML) and Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Shared Mechanisms of T Cell Killing, but Programmed Death Ligands Render CP-CML and Not BC-CML GVL Resistant Catherine Matte-Martone, Srividhya Venkatesan, Hung Sheng Tan, The Journal of Immunology Hematological MalignancyT Cell KillingCell TherapyBc-cml Gvl ResistantMixed-phenotype Acute Leukemia	2011	29

Page 1